Abbott

YTD

ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

114,000

Employees114,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

114,000

Employees114,000

ABT Key Statistics

Market cap

193.14B

Market cap193.14B

Price-Earnings ratio

29.71

Price-Earnings ratio29.71

Dividend yield

2.17%

Dividend yield2.17%

Average volume

13.94M

Average volume13.94M

High today

$111.27

High today$111.27

Low today

$109.50

Low today$109.50

Open price

$110.50

Open price$110.50

Volume

11.72M

Volume11.72M

52 Week high

$141.23

52 Week high$141.23

52 Week low

$105.27

52 Week low$105.27

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $111.00. The company's market cap stands at 193.14B, with a P/E ratio of 29.71 and a dividend yield of 2.2%.

During the trading session on 2026-02-10, Abbott(ABT) shares reached a daily high of $111.27 and a low of $109.50. At a current price of $111.00, the stock is +1.4% higher than the low and still -0.2% under the high.

Trading activity shows a volume of 11.72M, compared to an average daily volume of 13.94M.

The stock's 52-week range extends from a low of $105.27 to a high of $141.23.

ABT News

Simply Wall St 1d

Assessing Abbott Laboratories Valuation After New AFib Catheter And Pulsed Field Ablation Data

Advertisement Why Abbott Laboratories (ABT) is back on investors’ radar Abbott Laboratories (ABT) is drawing fresh attention after late breaking clinical data...

TipRanks 4d

Abbott announce new clinical data from AFib therapies studies

Abbott (ABT) announced new clinical data from two late-breaking presentations at AF Symposium in Boston that demonstrate the strong safety and efficacy of the c...

Simply Wall St 4d

How Soft Guidance, Exact Sciences Deal, and Device Scrutiny Will Impact Abbott Laboratories Investors

In late January 2026, Abbott Laboratories reported revenue and profit guidance below Wall Street expectations, highlighted ongoing weakness in its pediatric nut...

Analyst ratings

71%

of 31 ratings

Buy

71%

Hold

29%

Sell

More ABT News

Simply Wall St 7d

Abbott CEO Share Purchase Highlights $21b Exact Sciences Deal And Valuation

Abbott Laboratories (NYSE:ABT) CEO Robert Ford bought company shares after the latest earnings release and investor reaction. The purchase followed Abbott's an...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.